The glycolysis pathway that is preferentially utilized by cancer cells is impaired by p53 through direct downregulation of hexokinase 2, an enzyme involved in glycolysis and indirectly through inducing the expression of PARK2, a negative regulator of HIF-1a [183,184]. The gene discussed is TP53; the disease is cancer.